<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">475818660</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180406123816.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170329e20000701xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s002280000137</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s002280000137</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Methylation of 6-mercaptopurine and 6-thioguanine by thiopurine S-methyltransferaseA comparison of activity in red blood cell samples of 199 blood donors</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="b">A comparison of activity in red blood cell samples of 199 blood donors</subfield>
   <subfield code="c">[T. Kröplin, H. Iven]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Objectives: To compare 6-mercaptopurine (6-MP) and 6-thioguanine (6-TG) as substrates for the methylation reaction catalysed by the enzyme thiopurine S-methyltransferase (TPMT). Methods: TPMT activity in haemolysed red blood cells of healthy blood donors was determined twice, using the same experimental setting and equal molar concentrations of 6-TG and 6-MP as substrates. After extraction, the reaction products 6-methyl-TG and 6-methyl-MP were quantified using specific high-performance liquid chromatography procedures. Results: The medians of the TPMT activities from 199 blood donors were 54.4 nmol 6-MTG g−1Hb h−1 when measured with 6-TG as the substrate and 35.8 nmol 6-MMP g−1 Hb h−1 when measured with 6-MP. The correlation coefficient for the 199 pairs of values was 0.8695. On average, TPMT activity was 34% lower with 6-MP as substrate than with 6-TG as substrate.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer-Verlag Berlin Heidelberg, 2000</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Key words 6-Thioguanine</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">6-Mercaptopurine</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Thiopurine S-methyltransferase</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Kröplin</subfield>
   <subfield code="D">T.</subfield>
   <subfield code="u">Department of Experimental and Clinical Pharmacology and Toxicology, Lübeck Medical University, Ratzeburger Allee 160, D-23538 Lübeck, Germany e-mail: iven@medinf.mu-luebeck.de Tel.: +49-451-5002682; Fax: +49-451-5006573, DE</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Iven</subfield>
   <subfield code="D">H.</subfield>
   <subfield code="u">Department of Experimental and Clinical Pharmacology and Toxicology, Lübeck Medical University, Ratzeburger Allee 160, D-23538 Lübeck, Germany e-mail: iven@medinf.mu-luebeck.de Tel.: +49-451-5002682; Fax: +49-451-5006573, DE</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s002280000137</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s002280000137</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Kröplin</subfield>
   <subfield code="D">T.</subfield>
   <subfield code="u">Department of Experimental and Clinical Pharmacology and Toxicology, Lübeck Medical University, Ratzeburger Allee 160, D-23538 Lübeck, Germany e-mail: iven@medinf.mu-luebeck.de Tel.: +49-451-5002682; Fax: +49-451-5006573, DE</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Iven</subfield>
   <subfield code="D">H.</subfield>
   <subfield code="u">Department of Experimental and Clinical Pharmacology and Toxicology, Lübeck Medical University, Ratzeburger Allee 160, D-23538 Lübeck, Germany e-mail: iven@medinf.mu-luebeck.de Tel.: +49-451-5002682; Fax: +49-451-5006573, DE</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
